Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dimitrios Chatzidimitriou is active.

Publication


Featured researches published by Dimitrios Chatzidimitriou.


Vascular Health and Risk Management | 2009

Antiatherogenic effects of vitamin E: the search for the Holy Grail

Dimitrios Kirmizis; Dimitrios Chatzidimitriou

Vitamin E, a naturally occurring antioxidant, has been found to reduce atherosclerotic lesion formation in animal models as well as cardiovascular morbidity in several observational studies. However, a number of case-control and prospective cohort studies failed to confirm its value in the primary and secondary prevention of morbidity and mortality from coronary artery disease. Several small or larger randomized interventional trials completed to date failed to resolve the conflict. Notably, even in large, well-conducted prospective epidemiologic studies, the potential effects of residual confounding may be on the same order of magnitude as the reported benefit. The response to vitamin E supplementation in specific patient subpopulations with chronic inflammation and/or higher degrees of oxidative stress has not been studied as yet. Therefore, further large randomized interventional trials are warranted to clarify accurately the role of vitamin E in the primary and secondary prevention of atherosclerotic coronary disease in these patient groups.


Journal of The European Academy of Dermatology and Venereology | 2011

Investigation of cytokine levels and their association with SCORAD index in adults with acute atopic dermatitis

Efstratios Vakirlis; Elizabeth Lazaridou; Thrasivoulos Tzellos; S. Gerou; Dimitrios Chatzidimitriou; D. Ioannides

Background  Atopic dermatitis (AD) is a chronic inflammatory skin disease with increasing frequency over the last decades, especially in adults. Cytokines orchestrate atopic skin inflammation.


Future Microbiology | 2012

Atherosclerosis and infection: is the jury still not in?

Dimitrios Chatzidimitriou; Dimitrios Kirmizis; Eleni Gavriilaki; Maria Chatzidimitriou; Nikolaos Malisiovas

Atherosclerosis is a chronic inflammatory process accounting for increased cardiovascular and cerebrovascular morbidity and mortality. A wealth of recent data has implicated several infectious agents, mainly Chlamydophila pneumoniae, Helicobacter pylori, CMV and periodontal pathogens, in atherosclerosis. Thus, we sought to comprehensively review the available data on the topic, exploring in particular the pathogenetic mechanisms, and discuss anticipated future directions.


Journal of Applied Physics | 2015

Rigorous calculation of nonlinear parameters in graphene-comprising waveguides

Dimitrios Chatzidimitriou; Alexandros Pitilakis; Emmanouil E. Kriezis

We describe a rigorous formalism for the calculation of the nonlinear parameter of arbitrary three-dimensional nanophotonic graphene-comprising waveguides. Graphene is naturally implemented as a zero-thickness conductive sheet, modeled solely by complex linear and nonlinear surface conductivity tensors, whose values are extracted from theoretical models. This representation is compared to the more commonly employed equivalent bulk-medium representation and is found superior. We numerically calculate the nonlinear parameters of several optical waveguide archetypes overlaid with infinite graphene monolayers, including silicon-wire and plasmonic metal-slot and metal-stripe configurations. The metal-slot configuration offers the most promising performance for Kerr-type nonlinear applications. Finally, we apply the same formalism to probe the potential of graphene nanoribbon waveguide nonlinearity in the terahertz band.


Oral Oncology | 2014

Detection and typing of human papillomaviruses (HPV) in malignant, dysplastic, nondysplastic and normal oral epithelium by nested polymerase chain reaction, immunohistochemistry and transitional electron microscopy in patients of northern Greece.

E. Blioumi; Dimitrios Chatzidimitriou; Ch. Pantzartzi; Th. Katopodi; Georgios Tzimagiorgis; E.-N. Emmanouil-Nikoloussi; Markopoulos Ak; C. Kalekou; Nicolas Lazaridis; Eudoxia Diza; D. Antoniades

OBJECTIVES To evaluate the role of HPV in oral carcinogenesis, we examined the prevalence of HPV in malignant, potentially malignant and normal oral epithelium and studied the relation of HPV prevalence with other factors obtained from the patients records. MATERIALS AND METHODS Our material consisted of 291 tissue specimens from 258 individuals. From every individual formalin fixed and paraffin embedded tissues were examined by nested Polymerase Chain Reaction (NPCR) for the detection of HPV DNA and by immunohistochemistry (IHC) for the in situ detection of HPV L1 protein. Positive PCR products were sequenced in order to type HPVs. Also 33 fresh tissues were obtained, fixed and used to detect HPV particles by transitional electron microscopy (TEM). RESULTS HPV was detected in 32.9% of the tissue specimens by NPCR, in 4.7% by immunohistochemistry and in 28.1% by TEM. In detail, by nested PCR HPV L1 DNA was detected in 40% of normal tissues, 40% of fibromas, 35.8% of non-dysplastic leukoplakias, 31.6% of dysplastic leukoplakias and 22.2% of oral squamous cell carcinomas. The HPV viral load of 96.5% of the samples was very low (1 viral copy per 10(2)-10(4) cells). HPV16 prevails in all histological groups in 89-100%. CONCLUSION We conclude that HPV does not seem, from the specific sample examined, to play a substantial role in oral carcinogenesis. However, it cannot be excluded that HPV could be involved in oral carcinogenesis only in cases with high viral load or at early stages of carcinogenesis possibly through the hit-and-run mechanism.


Drug Design Development and Therapy | 2009

Pleiotropic vasoprotective effects of statins: The chicken or the egg?

Dimitrios Kirmizis; Dimitrios Chatzidimitriou

Statins (3-hydroxy-3-methyl glutaryl coenzyme A [HMG-CoA] reductase inhibitors) are the most commonly used lipid-lowering drugs. Their main lipid-lowering effect is achieved by an increase in the expression of low-density lipoprotein cholesterol receptors associated with inhibition of cholesterol synthesis through inhibition of HMG-CoA reductase – the first and rate-limiting step in cholesterol synthesis. However, beyond cholesterol synthesis inhibition, inhibition of the HMG-CoA reductase affects as well the synthesis of other molecules with significant roles in different, yet often intercalating, metabolic pathways. On this basis, and supported by an increasing series of advocating epidemiological and experimental data, an extended dialogue has been established over the last few years regarding the nonlipid or “pleiotropic” actions of statins.


European Journal of Clinical Microbiology & Infectious Diseases | 2015

Double- and multi-carbapenemase-producers: the excessively armored bacilli of the current decade

G. Meletis; Dimitrios Chatzidimitriou; Nikolaos Malisiovas

Multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative nosocomial pathogens commonly carry one carbapenemase gene conferring resistance to carbapenems and other beta-lactam antibiotics. However, increasing reports show that double-carbapenemase-producing (DCP) and even multi-carbapenemase-producing (MCP) bacteria are emerging in some parts of the world, diminishing further, in some cases, the already limited treatment options. In the present review, the up-to-date reports of DCP and MCP isolates are summarized and concerns regarding their emergence are discussed.


Journal of Medical Virology | 2010

Hematopoietic cell transplantation and emerging viral infections

Dimitrios Chatzidimitriou; Eleni Gavriilaki; Ioanna Sakellari; E. Diza

Viral infections remain important causes of morbidity and mortality in hematopoietic cell transplant recipients. More recent developments in preparative regimens and graft manipulations, as well as the control of well‐recognized post‐transplant infections by the introduction of prophylaxis and preemptive strategies, have influenced the timing and the epidemiology of infections. As new pathogens, such as human metapneumovirus (HMPV), human bocavirus, human coronaviruses HCoV‐NL63 and HCoV‐HKU1, human herpesviruses HHV‐6 and HHV‐7, and polyomaviruses, have emerged, it is fundamental to determine the significance of the newly discovered viruses and their role in the transplantation field. This article summarizes recent data on epidemiology and laboratory diagnosis of new pathogens, as well as clinical features and management of the associated infectious complications. J. Med. Virol. 82:528–538, 2010.


Journal of Child Neurology | 2010

Acquired Toxoplasmosis Accompanied by Facial Nerve Palsy in an Immunocompetent 5-Year-Old Child

Assimina Galli-Tsinopoulou; Ioannis Kyrgios; Eleni Z. Giannopoulou; Styliani Gourgoulia; Ioanna Maggana; Elina Katechaki; Dimitrios Chatzidimitriou; Athanasios Evangeliou

Acquired toxoplasmosis, although relatively common in children, is usually asymptomatic but can also be clinically manifested by a benign and self-limited infectious mononucleosis-like syndrome. Neurological complications are very rare in immunocompetent children. The authors report a 5-year-old boy who presented with cervical lymphadenopathy because of acquired toxoplasmosis accompanied with unilateral facial nerve paralysis. Toxoplasma gondii DNA detection in blood by polymerase chain reaction, as well as elevated specific immunoglobulin M antibodies against it, established the diagnosis. Characteristic brain lesions on magnetic resonance imaging were absent and ophthalmologic examination revealed no inflammatory lesions in the retina and choroid. Treatment with pyrimethamine, sulfadiazine, and folic acid resulted in a complete recovery after 2 months of therapy. Although rare, acute facial nerve paralysis of unknown origin can be caused by acquired toxoplasmosis even in the immunocompetent pediatric population. Elevated titers of specific antibodies and the presence of parasite’s DNA are key findings for the correct diagnosis.


Journal of Spinal Cord Medicine | 2014

Circulating angiogenic biomolecules at rest and in response to upper-limb exercise in individuals with spinal cord injury

Angelo V. Vasiliadis; Andreas Zafeiridis; Konstantina Dipla; Nikiforos Galanis; Dimitrios Chatzidimitriou; Antonios Kyparos; Michalis G. Nikolaidis; Ioannis S. Vrabas

Abstract Objective Individuals with spinal cord injury (SCI) show structural and functional vascular maladaptations and muscle loss in their lower limbs. Angiogenic biomolecules play important roles in physiological and pathological angiogenesis, and are implicated in the maintenance of muscle mass. This study examined the responses of angiogenic molecules during upper-limb aerobic exercise in patients with SCI and in able-bodied (AB) individuals. Methods Eight SCI patients with thoracic lesions (T6–T12, ASIA A) and eight AB individuals performed an arm-cranking exercise for 30 minutes at 60% of their VO2max. Plasma concentrations of vascular endothelial growth factor (VEGF-A165), VEGF receptor 1 (sVEGFr-1), VEGF receptor 2 (sVEGFr-2), metalloproteinase 2 (MMP-2), and endostatin were measured at rest, after exercise, and at 1.5 and 3.0 hours during recovery. Results The two-way analysis of variance showed non-significant main effects of “group” and significant main effects of “time/exercise” for all angiogenic biomolecules examined (P < 0.01–0.001). The arm-cranking exercise significantly increased plasma concentrations of VEGF, sVEGFr-1, sVEGFr-2, MMP-2, and endostatin in both groups (P < 0.001–0.01). The magnitude of the increase was similar in both patients with SCI and AB individuals, as shown by the non-significant group × time interaction for all angiogenic parameters. Conclusions Upper-limb exercise (arm-cranking for 30 minutes at 60% of VO2max) is a sufficient stimulus to trigger a coordinated circulating angiogenic response in patients with SCI. The response of angiogenic molecules to upper-limb aerobic exercise in SCI appears relatively similar to that observed in AB individuals.

Collaboration


Dive into the Dimitrios Chatzidimitriou's collaboration.

Top Co-Authors

Avatar

Angeliki Melidou

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Georgia Gioula

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Dimitrios Kirmizis

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Maria Exindari

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Eleni Gavriilaki

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Fani Chatzopoulou

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Nikolaos Malisiovas

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Georgios Tzimagiorgis

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Lemonia Skoura

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Emmanouil E. Kriezis

Aristotle University of Thessaloniki

View shared research outputs
Researchain Logo
Decentralizing Knowledge